This could be another watershed year for Rx-to-OTC switches. The probable conversion of ulcer treatment Prilosec is expected to bring big-time sales, while the possible changeover of emergency contraceptive Plan B is likely to generate big-time controversy. Prilosec is a top-selling ulcer treatment from drug maker AstraZeneca, London, and the company expects over-the-counter approval by the Food and Drug Administration this summer. It has already received preliminary sanction by an FDA ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.